original ) (raw )Tissue prostatic specific antigen (T-PSA) : A way to predict and understand the development of prostate cancer
Mirtha Grande
2001
View PDFchevron_right
Prostate-specific antigen and other prostate cancer markers
Ulf-Håkan Stenman
Urology, 2000
View PDFchevron_right
Cellular PSA in benign and malignant prostate
Frank Gelder
The Prostate, 1995
View PDFchevron_right
Comparison of Caveolin-1 and PSA in Prostate Adenocarcinoma
Özkan Onuk
Journal of Academic Research in Medicine, 2019
View PDFchevron_right
Regulation of androgen receptor (AR) and prostate specific antigen (PSA) expression in the androgen-responsive human prostate LNCaP cells by ethanolic extracts of the Chinese herbal preparation, PC-SPES
tze-chen hsieh
IUBMB Life, 1997
View PDFchevron_right
Prostate‐specific antigen: A review of the validation of the most commonly used cancer biomarker
Javier Hernandez
Cancer, 2004
View PDFchevron_right
The pathophysiologic basis of prostate cancer review
Bhargava Gottam
International Journal of Science and Research Archive
View PDFchevron_right
Evaluation of prostate-specific antigen and prosttic acid phosphatase as prostate cancer markers
Leslie Shaw
Urology, 1986
View PDFchevron_right
The cellular and molecular basis of prostate cancer
Philip Cornford
BJU International, 2001
View PDFchevron_right
Alterations in Lipoxygenase and Cyclooxygenase-2 Catalytic Activity and mRNA Expression in Prostate Carcinoma
Suzanne Manning
Neoplasia, 2001
View PDFchevron_right
Lipidomics as a Diagnostic Tool for Prostate Cancer
Michal Markuszewski
Cancers
View PDFchevron_right
Current Trends in the Management of Prostate Cancer
Ifemed Journal
Journal of the Obafemi Awolowo University Medical Students’ Association, 2023
View PDFchevron_right
Can prostate-specific antigen be used as a valid end point to determine the efficacy of chemotherapy for advanced prostate cancer?
CT anthony
World Journal of Urology, 1996
View PDFchevron_right
Arachidonic acid metabolism in benign and malignant prostatic tissuein vitro: Effects of fatty acids and cyclooxygenase inhibitors
L. Moffat , S. McClinton
International Journal of Cancer, 1994
View PDFchevron_right
Cytosolic PhospholipaseA2-A: A Potential Therapeutic Target for Prostate Cancer
Fiona Maclean
2008
View PDFchevron_right
Can Complexed Prostate Specific Antigen Enhance Prostate Cancer Detection in Japanese Men?
Yoshio Naya
European Urology, 2004
View PDFchevron_right
Immunohistochemical analysis of the extrinsic apoptosis process in the non-neoplastic and neoplastic prostate
Alev Deresoy
Turkish Journal of Pathology
View PDFchevron_right
Prostate-Specific Antigen (Psa), a Biomarker of Neoplastic Prostatic Disease
Raluca Dumache
… of University of …, 2008
View PDFchevron_right
Molecular Markers for Prostate Cancer Diagnosis
Munirah Salleh
2015
View PDFchevron_right
Current and proposed biologic markers in prostate cancer
Thomas Wheeler
Journal of Cellular Biochemistry, 1992
View PDFchevron_right
Biomarkers for Prostate Cancer
Joseph Pazona
Annual Review of Medicine, 2009
View PDFchevron_right
Co-expression and impact of prostate specific membrane antigen and prostate specific antigen in prostatic pathologies
ridha oueslati
2010
View PDFchevron_right
An Overview on Prostate Pathophysiology: New Insights into Prostate Cancer Clinical Diagnosis
Gustavo Simoes
Pathophysiology - Altered Physiological States, 2018
View PDFchevron_right
Prostate-Specific Antigen, High-Molecular-Weight Cytokeratin (Clone 34βE12), and/or p63
Lakshmi Priya
American Journal of Clinical Pathology, 2006
View PDFchevron_right
Prostate Specific Antigen in the Diagnosis and Treatment of Adenocarcinoma of the Prostate. IV. Anti-Androgen Treated Patients
Slavica Usaj
The Journal of Urology, 1989
View PDFchevron_right
Evidence That Arachidonate 15-Lipoxygenase 2 Is a Negative Cell Cycle Regulator in Normal Prostate Epithelial Cells
Dhyan Chandra
Journal of Biological Chemistry, 2002
View PDFchevron_right
Chapter 2 Biomarkers for Diagnosis and Prognosis of Prostate Cancer
Meghan Rice
2019
View PDFchevron_right
The control of prostate-specific antigen expression and gene regulation by pharmacological agents
William Figg
Pharmacological reviews, 2001
View PDFchevron_right
Immunohistochemical evaluation of the expression of prostate tumor-association markers in the nude mouse human prostate carcinoma heterotransplant lines PC-82, PC-EW, and PC-EG
George Wright
The Prostate, 1990
View PDFchevron_right
Current status and new approaches in prostate cancer diagnosis
Agnieszka Pedrycz
Polish Journal of Public Health, 2018
View PDFchevron_right
Cytoplasmic induction and over-expression of cyclooxygenase-2 in human prostate cancer: implications for prevention and treatment
Khurram Chaudhary
BJU International, 2001
View PDFchevron_right
The Profile of Prostate Epithelial Cytokines and its Impact on Sera Prostate Specific Antigen Levels
Ricardo Paniagua
Inflammation, 2009
View PDFchevron_right
Cytosolic Phospholipase A2- : A Potential Therapeutic Target for Prostate Cancer
Fiona Maclean
Clinical Cancer Research, 2008
View PDFchevron_right
The value of tumor markers in men with metastatic prostate cancer undergoing [ 177 Lu]Lu‐PSMA therapy
Paula Linden
The Prostate, 2019
View PDFchevron_right
Arachidonic Acid Pathway Members PLA2G7, HPGD, EPHX2, and CYP4F8 Identified as Putative Novel Therapeutic Targets in Prostate Cancer
Gerald Verhaegh
The American Journal of Pathology, 2011
View PDFchevron_right